Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Ochs

Showing results (111-120 of 113) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 113 results.
The New England Journal of Medicine|November 1, 1984
Treatment of advanced non-Hodgkin's lymphoma with recombinant leukocyte A interferonK A Foon, S A Sherwin, P G Abrams, et al.
International Journal of Radiation Oncology, Biology, Physics|December 1, 1996
Clinical value of proton magnetic resonance spectroscopy for differentiating recurrent or residual brain tumor from delayed cerebral necrosisJ S Taylor, J W Langston, W E Reddick, et al.
JAMA|October 23, 2003
Efficacy of gefitinib, an inhibitor of the epidermal growth factor receptor tyrosine kinase, in symptomatic patients with non-small cell lung cancer: a randomized trialMark G Kris, Ronald B Natale, Roy S Herbst, et al.
Pageof 12

Showing results (111-120 of 113) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 113 results.
The New England Journal of Medicine|November 1, 1984
Treatment of advanced non-Hodgkin's lymphoma with recombinant leukocyte A interferonK A Foon, S A Sherwin, P G Abrams, et al.
International Journal of Radiation Oncology, Biology, Physics|December 1, 1996
Clinical value of proton magnetic resonance spectroscopy for differentiating recurrent or residual brain tumor from delayed cerebral necrosisJ S Taylor, J W Langston, W E Reddick, et al.
JAMA|October 23, 2003
Efficacy of gefitinib, an inhibitor of the epidermal growth factor receptor tyrosine kinase, in symptomatic patients with non-small cell lung cancer: a randomized trialMark G Kris, Ronald B Natale, Roy S Herbst, et al.
Pageof 12